comparemela.com

Latest Breaking News On - Parul bhatt - Page 1 : comparemela.com

Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India

Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Announcing India s first clinically tested medicine for COVID-19 management and treatment AAYUDH Advance

Ahmedabad (Gujarat) [India], April 16 (ANI/NewsVoir): With the second wave of COVID-19 pandemic wreaking havoc across the world, a breakthrough has been achieved to provide effective medical care and a treatment for COVID-19 patients. AAYUDH Advance , a plant-based liquid formulation, has been found to be highly effective and safe in not one but two detailed human clinical trials conducted at two government hospitals in Ahmedabad. After just four days of treatment with AAYUDH Advance , it successfully and effectively reduced the viral load in the patients, without any reported side effects. All the COVID-19 patients that were treated with AAYUDH Advance recovered (i.e. turned COVID Negative) and witnessed significant improvements in symptoms like body temperature, cough, and shortness of breath.

કોરોના વૅક્સિનને લઈને અમદાવાદથી ભારત માટે આવ્યા મહત્વના સમાચાર, જાણો ડૉક્ટરે શું કહ્યું | Co vaccine in Ahmedabad India human trial

કોરોના વૅક્સિનને લઈને અમદાવાદથી ભારત માટે આવ્યા મહત્વના સમાચાર, જાણો ડૉક્ટરે શું કહ્યું | Co vaccine in Ahmedabad India human trial
vtvgujarati.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vtvgujarati.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.